The firm will study its autologous cell therapy alone and in combination with Eisai's Lenvima in patients with hepatitis B-driven hepatocellular carcinoma.
I saw this as something that I thought would change me,” said Clark Gamblin, a cancer surgeon in Milwaukee. “And change me ...
Vancomycin could offer new therapeutic option for patients with a type of inflammatory bowel disease
An antibiotic used to treat infective diarrhoea could be an effective drug for a type of inflammatory bowel disease, a new study has found.
Researchers describe successful tumor removal through the use of immunotherapy and targeted radiation therapy (TARE), in a patient previously considered ineligible for the procedure.
Rare Disease Day is February 28. Primary sclerosing cholangitis or PSC is a rare liver disease characterized by progressive ...
Delcath Systems markets Hepzato Kit for the treatment of uveal melanoma with unresectable hepatic metastases. Click here to read my analysis of DCTH stock.
When a Wheaton woman’s cancer treatment was denied days before it was supposed to start, her desperate posts for help gained ...
Investigator Award has been awarded to two surgeon-scientists at the National Cancer Centre Singapore (NCCS) to pursue novel research in liver cancer and head and neck cancers. Globally, liver cancer ...
Hepatocellular carcinoma (HCC) is an aggressive disease that accounts for 80%-90% of all primary liver cancers. Previous findings have shown fibroblast growth factor 19 (FGF-19) to be overexpressed in ...
Explore how the liver functions, common liver conditions, and tips to maintain liver health through lifestyle changes like ...
In a groundbreaking medical achievement in the U.K., a 32-year-old woman from Manchester has undergone the country's first ...
The research team engineered these hydrogels to deliver a specific peptide that targets hepatocellular carcinoma (HCC), the most common type of primary liver cancer. The LPH system demonstrated ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results